A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Japanese Participants. Part A (P05957)
Status:
Completed
Trial end date:
2006-10-19
Target enrollment:
Participant gender:
Summary
The objective of the trial was to establish the dose-response relation of sugammadex (Org
25969) given as a reversal agent of rocuronium or vecuronium at 1-2 PTC during sevoflurane
anesthesia for Japanese participants.